Status:
COMPLETED
Risk Factors for Adverse Outcomes in Sepsis
Lead Sponsor:
Qin Zhang
Conditions:
Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
This study will adopt a retrospective clinical cohort design and include a certain scale of sepsis patients as research objects to find the risk factors for adverse outcomes in patients with sepsis. B...
Detailed Description
This study was designed as a retrospective single-center clinical study. By searching sepsis patients on the Tongji Cloud platform, the investigators will collect clinical data of patients diagnosed w...
Eligibility Criteria
Inclusion
- over 18 years old;
- meet the diagnostic criteria for sepsis;
- Duration of hospitalization: lasting more than 24 hours;
- no important comorbidities, such as heart failure, liver and kidney insufficiency, malignant tumor, etc.
- Antibiotic use: The time to start antibiotic treatment should not exceed 48 hours.
Exclusion
- less than 18 years old;
- Clinical anti-infective therapy: Start long-term anti-infective therapy within 14 days before the expected time point of infection;
- Duration of hospitalization: less than 24 hours;
- The presence of other important complications, such as heart failure, liver and kidney insufficiency, and malignant tumors;
- The presence of other important complications, such as heart failure, liver and kidney insufficiency, and malignant tumors;
- The presence of other infectious diseases, such as tuberculosis, HIV/AIDS, etc.
Key Trial Info
Start Date :
January 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
10313 Patients enrolled
Trial Details
Trial ID
NCT06541600
Start Date
January 1 2003
End Date
January 1 2023
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030